Laurie Ray
Family · New Orleans, LANPI 1396015293
Payments from drug & device makers
Across 63 payments — averaging $65.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$2K
- AbbVie$439
- Jazz Pharmaceuticals Inc.$259
- Amgen$132
- E.r. Squibb & Sons, L.L.C.$125
- GSK$125
- plus $984 from 19 others
What the payments were for
- Consulting fees$1,15528%
- Food & beverage$2,82768%
- Education$1644%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 14 | $2,082 |
| AbbVie | 7 | $439 |
| Jazz Pharmaceuticals Inc. | 3 | $259 |
| Amgen | 2 | $132 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| GSK | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
| AstraZeneca | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $109 |
| Johnson & Johnson | 3 | $84 |
| Neurelis, Inc. | 1 | $82 |
| Bristol Myers Squibb | 4 | $69 |
| Shionogi Inc | 1 | $52 |
| Taiho Oncology, Inc. | 2 | $48 |
| Sobi, Inc | 2 | $46 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Servier Pharmaceuticals LLC | 2 | $32 |
| Genentech USA, Inc. | 1 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Pharmaessentia USA Corporation | 1 | $27 |
| Merck | 1 | $23 |
| Epizyme, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| Apellis Pharmaceuticals, Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,146 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acyclovir | 29 | $278 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $70 |
Paid to pharmacies, not to this prescriber.
Other family in New Orleans
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Robert ByramNew Orleans$49K
- Amy SchmittNew Orleans$48K
- Eric BabineauxNew Orleans$32K
- Cherie AlbroNew Orleans$29K
- Aimee ScroggsNew Orleans$20K
- Kelly BaquetNew Orleans$18K
- Lori LemoineNew Orleans$17K
- Jennifer GreenheckNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.